Filter
51
Text search:
L.
Mofenson
Featured
Recommendations
3
New Publications
3
Language
Document type
No document type
35
Guidelines
7
Studies & Reports
6
Manuals
3
Countries / Regions
Africa
3
Zimbabwe
2
Kenya
2
Thailand
2
Senegal
1
Côte d’Ivoire / Ivory Coast
1
Ethiopia
1
Cameroon
1
Uganda
1
Haiti
1
Zambia
1
Tanzania
1
Rwanda
1
Malawi
1
Eswatini/ Swaziland
1
Brazil
1
Lesotho
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
9
Countries
4
Women & Child Health
2
Public Health
1
Toolboxes
HIV
38
TB
5
COVID-19
3
Mental Health
1
Downloaded from https://aidsinfo.nih.gov/guidelines on 10/19/2019
Developed by the HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV—A Working Group of the Office
of AIDS Research Advisory Council (OARAC)
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
Review
published: 12 August 2016 doi: 10.3389/fpubh.2016.00166
Frontiers in Public Health | www.frontiersin.org 1 August 2016 | Volume 4 | Article 166
Downloaded from https://aidsinfo.nih.gov/guidelines on 10/19/2019
Recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America and the Pediatric Infectious Diseases Society
(This g
...
The WHO COVID-19 LENS (Living Evidence Synthesis) working group consolidated available evidence, based on rapid reviews of the literature and results of a living systematic review on pregnancy and COVID-19 (up to October 7, 2020), on potential mechanisms of vertical transmission of infectious pathog
...
Manuel sur le sida pédiatrique en Afrique
recommended
Ce manuel donne une vue d’ensemble des connaissances scientifiques actuelles sur l’infection à VIH ainsi que des technologies et des outils utilisés pour prévenir cette infection, pour améliorer la qualité de vie des personnes infectées et
...
Downloaded from https://aidsinfo.nih.gov/guidelines on 11/27/2019
Visit the AIDSinfo website to access the most up-to-date guideline.
Register for e-mail notification of guideline updates at https://aidsinfo.nih.gov/e-news.
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
AIDS Research and Therapy 2015, 12:12 (24 April 2015)
Definition and categorization of the time of vertical transmission of SARS-CoV-2
Scientific report 8 February 2021
This policy brief describes key HIV viral load thresholds and the available viral load testing approaches for monitoring how well antiretroviral therapy is working for people living with HIV. It provides clarification for and elaborates upon the current treatment monitoring algorithm from the Consol
...
As of 15 May 2020, more than 4 million confirmed cases of COVID-19, including more than 285,000 deaths have been reported to WHO. The risk of severe disease and death has been highest in older people and in persons with underlying noncommunicable diseases (NCDs), such as hypertension, cardiac diseas
...
PLOS ONE | DOI:10.1371/journal.pone.0144057 December 14, 2015
Supplement Article
J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018 www.jaids.com
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi
...
Review
www.co-hivandaids.com
Volume 12 Number 4 July 2017
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i
...
